人工智能在痴呆症中的应用
Masashi Kameyama1, Yumi Umeda-Kameyama2,3
1AI and Theoretical Image Processing, Research Team for Neuroimaging, Tokyo Metropolitan Institute for Geriatrics and Gerontology, Tokyo, Japan.
Geriatrics & gerontology international
|November 2, 2023
概括
人工智能 (AI) 为痴呆症护理提供了变革性的工具. 人工智能在图像分类和自然语言处理方面的应用有助于早期诊断和治疗痴呆症的策略.
科学领域:
- 人工智能的人工智能
- 医学诊断 医学诊断 医学诊断
- 老年学是一门学科.
背景情况:
- 人工智能 (AI) 已经迅速发展,在图像分类和自然语言处理 (NLP) 方面取得了重大进展.
- 这些人工智能技术,包括卷积神经网络和变压器,已经彻底改变了各种领域.
- 人工智能在解决痴呆症诊断和治疗方面的挑战方面的潜力是一个越来越受关注的领域.
研究的目的:
- 引入和审查人工智能系统在痴呆症诊断和治疗中的各种应用.
- 突出人工智能技术如何提高痴呆症的早期检测和管理.
主要方法:
- 对人工智能应用的审查,包括面部特征识别的图像分类和MRI扫描中的白内障症分类.
- 包括对象检测AI用于微出血检测和支持护理.
- 将自然语言处理 (NLP) 整合到人工智能中,用于在对话中检测痴呆症,以及用于聊天机器人的功能.
主要成果:
- 人工智能支持的图像分类可以识别与痴呆症相关的面部特征,并在MRI上分类白内障病.
- 对象检测人工智能有助于识别微型出血并提供支持护理.
- NLP人工智能通过对话分析和通过聊天机器人检测痴呆症的潜力.
结论:
- 人工智能技术,包括图像分类,物体检测和NLP,显示出改变痴呆症诊断的重大前景.
- 这些人工智能应用可以导致更有效和更容易获得的痴呆症治疗策略.
- 人工智能的整合将对未来的痴呆症护理环境产生重大影响.
更多相关视频
06:46Automated, Long-term Behavioral Assay for Cognitive Functions in Multiple Genetic Models of Alzheimer's Disease, Using IntelliCage
Published on: August 4, 2018
12.2K
12:18A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
7.6K
相关概念视频
01:30Dementia
120
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
120
01:22Alzheimer's Disease: Treatment
197
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
197
01:20Introduction to Cognitive Psychology
503
Cognitive psychology is the field of psychology dedicated to examining how people think. It attempts to explain how and why we think the way we do by studying the interactions among human thinking, emotion, creativity, language, and problem-solving, as well as other cognitive processes. Cognitive psychology studies how information is processed and manipulated in remembering, thinking, and knowing.
This field emerged in the mid-20th century, following a period dominated by behaviorism, which...
This field emerged in the mid-20th century, following a period dominated by behaviorism, which...
503
01:26Alzheimer's Disease: Overview
498
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
498
01:30Cognitive Development During Adulthood
122
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
122
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
130
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
130